biostartr

A new way to fight Alzheimer´s disease!

  • Jun 23 2015 · 

Multi-targeted small molecule therapy to treat Alzheimer’s disease!

Amarit Biosciences is an innovative drug discovery company and focuses on novel chemistry based technologies to discover multi-targeted single-small molecule therapeutics for neurodegenerative disorders, especially Alzheimer’s disease (AD), for which there are no disease modifying or curative treatments yet.

 

Spindletop Capital

  • Jun 22 2015 · 

Spindletop Capital – Partners with exceptional leaders to build transformational healthcare companies.
Spindletop Capital focuses exclusively on healthcare investment opportunities. They strategically invest in companies – both within the region and nationally.

Investment Sectors:

  • Healthcare Services and Distribution
  • Biopharma and Specialty Pharmaceuticals
  • Healthcare IT
  • Medical Diagnostics and Devices

Source: http://spindletopcapital.com

Design driven mini-lab!

  • Jun 22 2015 · 

Amino, the tamagotchi for synthetic biology!

Amino is an intuitive bioengineering mini-lab that allows easy bacterial transformations and enables continuous growth of the culture. Inspired by tamagotchis, the genetic transformation of an organism´s DNA is performed by the user through guided interactions, resulting in their own synthetic organism, for which they can care for like you would a pet.


Source: http://julielegault.com/amino/

 

C elegans can replace vertebrate animals!

  • Jun 19 2015 · 

Your new standard to evaluate the systemic toxicity of cosmetic products!

CeleScreen offers an innovative alternative method to characterize the toxicity of cosmetic molecules, at the scale of a whole organism via the worm C elegans.
Since 2013 cosmetics regulation prohibits the realization of tests being important to evaluate toxicity on vertebrate animals.
By offering an optimal toxicological model at the organism scale with a scale-up technology CeleScreen represents a strong interest for cosmetics industrials!


Source: http://www.celescreen.com

Today´s promising startup – NEOGRAM

  • Jun 18 2015 · 

Improvement of pastures for a more sustainable livestock production!

The company´s product GRAMAX is a subtropical pasture of the variety Rhode Grass, molecularly enhanced to increase its forage quality.

Its main feature is a higher digestibility.

This allows increasing the efficiency of animal feed, positively impacting productivity while reducing greenhouse gases emissions of produced meat.


Source: http://www.neogram.com.ar

Weekly BIOStartr Newsletter

  • Jun 17 2015 · 

Keep up with BIOStartr and the biotech and startup scene and sign up to our weekly newsletter!

Take a look at this week’s BIOStartr newsletter here and subscribe now to get your weekly update

In this Issue

  • Meet your target audience on BIOStartr – Register your biotech on BIOStartr and benefit from the BIOStartr ecosystem consisting if investors and supporters worldwide
  • New biotechs on BIOStartr –  BIOStartr welcomes Anew green, RMD Biotech and Farm4Trade, three promising biotechs
  • New BIOStartr partner –  BIOStartr teams up with BioRiver
  • What is the main cause of death for 90% of startups? – See the 20 biggest reasons why startup companies fail
  • Weekly biotech news –  BIOStartr provides you with the most important headlines regarding biotech and startups of this week

Have you already heard about cell-free DNA?

  • Jun 17 2015 · 

Unleash the power of cell-free DNA!

Freenome is a technology company developing proprietary algorithms and novel methods to enable accurate diagnosis of clinical conditions. The platform utilizes the power of next-generation sequencing to bring about the dream of non-invasive, accurate and early detection of cancer…from 1 mL of blood.

Method: Extraction of circulating, cell-free DNA (cfDNA) that are expelled by the cells in the body from a sample of your blood. Tumor cells expel cfDNA with mutations associated with cancer called circulating tumor DNA (ctDNA).


Source: http://www.freeno.me

The ideas of tomorrow!

  • Jun 16 2015 · 

EvoRx has developed a revolutionary technology that enables the development of next generation treatments for today’s unmet therapeutic needs.
EvoRx can design orally available, cell permeable compounds to drug protein-protein interactions that were thought to be undruggable!

For more information about that highly innovative company have a look here


Source: http://www.evorxtechnologies.com

Today´s antiviral biotech!

  • Jun 15 2015 · 

Novel treatments for chronic viral infections!

ContraVir is developing targeted antiviral therapies with two drug candidates in clinical studies. FV-100, now in a pivotal Phase 3 trials, is a novel therapeutic drug candidate to treat herpes zoster, or shingles. ContraVir is also developing CMX157, a highly potent analog of the successful antiviral drug tenofovir DF (Viread®).

Read more about the opportunities of these drug candidates on http://contravir.com


Source: http://contravir.com

Shared Form

...23456...10...
peuterey outlet peuterey outlet peuterey outlet peuterey outlet woolrich outlet woolrich outlet woolrich outlet moncler outlet moncler outlet moncler outlet golden goose pas cher golden goose pas cher golden goose pas cher golden goose pas cher golden goose pas cher golden goose pas cher golden goose outlet golden goose outlet golden goose outlet golden goose outlet golden goose outlet golden goose outlet nike tn pas cher nike tn pas cher nike tn pas cher nike tn pas cher nike tn pas cher nike tn pas cher stone island outlet stone island outlet stone island outlet stone island outlet stone island outlet stone island outlet outlet moose knuckles moose knuckle canada max maillots max maillot pas cher stone island outlet stone island uk stone island outlet 2018 outlet stone island supreme outlet supreme outlet online